Günter U Höglinger Selected Research

Günter U Höglinger Research Topics

Disease

40	Parkinson Disease (Parkinson's Disease) 02/2024 - 09/2003
29	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 12/2023 - 11/2005
21	Tauopathies 02/2024 - 11/2005
20	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2023 - 11/2005
12	Alzheimer Disease (Alzheimer's Disease) 04/2024 - 12/2011
9	Parkinsonian Disorders (Parkinsonism) 11/2023 - 01/2004
8	Disease Progression 01/2024 - 10/2013
8	Synucleinopathies 01/2023 - 07/2014
7	Multiple System Atrophy 11/2023 - 01/2017
6	Atrophy 09/2023 - 04/2014
6	Corticobasal Degeneration 12/2021 - 01/2018
4	Neuroinflammatory Diseases 01/2024 - 12/2020
3	Prodromal Symptoms 11/2023 - 01/2019
3	Movement Disorders (Movement Disorder) 08/2021 - 01/2020
3	Cerebellar Ataxia (Dysmetria) 01/2019 - 02/2016
2	Dementia (Dementias) 11/2023 - 01/2017
2	Amyloidosis 10/2021 - 01/2021
2	Glioma (Gliomas) 05/2021 - 01/2014
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2020 - 01/2019
2	Brain Diseases (Brain Disorder) 01/2020 - 12/2011
2	Schizophrenia (Dementia Praecox) 12/2011 - 06/2011
1	Obesity 01/2024
1	Clinical Deterioration 01/2024
1	Macular Degeneration (Age-Related Maculopathy) 12/2023
1	Nausea 01/2023
1	REM Sleep Behavior Disorder 01/2023
1	Constipation 01/2023
1	Heart Arrest (Cardiac Arrest) 01/2023
1	Critical Illness (Critically Ill) 09/2022
1	Panic Disorder (Panic Attack) 01/2022
1	Confusion (Bewilderment) 01/2022
1	Hypokinesia (Bradykinesia) 01/2022
1	Pick Disease of the Brain (Pick's Disease) 12/2021
1	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 12/2021
1	Pantothenate Kinase-Associated Neurodegeneration (Hallervorden-Spatz Disease) 07/2021
1	Nervous System Heredodegenerative Disorders 07/2021
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2021
1	Migraine Disorders (Migraine) 01/2020
1	Coronary Disease (Coronary Heart Disease) 01/2020
1	Heart Diseases (Heart Disease) 01/2020
1	Myocardial Infarction 01/2020

Drug/Important Bio-Agent (IBA)

17	Biomarkers (Surrogate Marker)IBA 01/2024 - 10/2013
11	SynucleinsIBA 04/2024 - 02/2016
10	tau Proteins (tau Protein)IBA 12/2023 - 11/2005
8	Proteins (Proteins, Gene)FDA Link 01/2024 - 02/2016
8	alpha-SynucleinIBA 07/2022 - 11/2005
6	Amyloid (Amyloid Fibrils)IBA 01/2024 - 01/2021
6	Levodopa (L Dopa)FDA LinkGeneric 01/2022 - 10/2013
6	annonacinIBA 01/2017 - 01/2004
5	Protein Isoforms (Isoforms)IBA 11/2021 - 12/2011
4	Dopamine (Intropin)FDA LinkGeneric 02/2024 - 07/2004
4	MicroRNAs (MicroRNA)IBA 01/2023 - 01/2021
4	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 12/2021 - 11/2016
4	tideglusibIBA 01/2017 - 04/2014
4	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 05/2015 - 01/2010
3	Glucose (Dextrose)FDA LinkGeneric 11/2023 - 01/2021
3	Glucosylceramidase (Glucocerebrosidase)IBA 01/2023 - 09/2015
3	AntibodiesIBA 10/2022 - 01/2021
3	LigandsIBA 01/2021 - 07/2017
3	davunetideIBA 01/2017 - 07/2014
3	Oxidopamine (6 Hydroxydopamine)IBA 05/2015 - 03/2008
2	Amyloid beta-PeptidesIBA 04/2024 - 12/2021
2	gosuranemabIBA 11/2023 - 01/2021
2	Monoclonal AntibodiesIBA 11/2023 - 01/2021
2	DNA (Deoxyribonucleic Acid)IBA 09/2023 - 01/2014
2	venglustatIBA 01/2023 - 01/2022
2	tilavonemabIBA 10/2021 - 01/2021
2	PesticidesIBA 01/2020 - 11/2018
2	Phosphotransferases (Kinase)IBA 01/2017 - 08/2015
2	NeurotoxinsIBA 01/2017 - 01/2008
2	Dopamine Agonists (Dopamine Agonist)IBA 09/2015 - 10/2013
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 05/2015 - 12/2012
2	Glycogen Synthase (Synthase I)IBA 04/2014 - 04/2014
2	Neuregulin-1 (Neuregulin 1)IBA 12/2012 - 06/2011
2	neuromelaninIBA 02/2011 - 01/2007
2	AcetogeninsIBA 07/2007 - 01/2004
1	Apolipoproteins E (ApoE)IBA 12/2023
1	Glycoproteins (Glycoprotein)IBA 01/2023
1	ceramide glucosyltransferaseIBA 01/2023
1	AcidsIBA 01/2023
1	Untranslated RNA (Noncoding RNA)IBA 11/2022
1	Piwi-Interacting RNAIBA 11/2022
1	Transfer RNA (tRNA)IBA 11/2022
1	GlycosphingolipidsIBA 01/2022
1	Glucosylceramides (Glucocerebrosides)IBA 01/2022
1	Cholinergic Agents (Cholinergics)IBA 01/2022
1	Neuroprotective AgentsIBA 10/2021
1	IronIBA 07/2021
1	Prescription DrugsIBA 01/2021
1	Biocompatible Materials (Biomaterials)IBA 01/2021
1	ParaffinIBA 01/2021
1	Formaldehyde (Formol)FDA Link 01/2021
1	Protein AggregatesIBA 01/2021
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2021

Therapy/Procedure

12	Therapeutics 05/2021 - 10/2007
3	Activities of Daily Living (ADL) 01/2023 - 01/2020
2	Drug Therapy (Chemotherapy) 01/2019 - 01/2019
1	Neurological Rehabilitation 09/2022
1	Aftercare (After-Treatment) 10/2021
1	Immunotherapy 08/2021